Artelo Biosciences logo

Artelo Biosciences

ARTL | NASDAQ
Chart Builder DCF Calculator
$1.70
-$0.37 (-17.87%)
At close: Nov 16, 2026, 4:00 PM ET
$1.69
-$0.01 (-0.64%)
After-hours: Nov 16, 2026, 7:58 PM ET
-17.87%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
18.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1001/1021 (Top 98%)

Key Statistics

Market Data

Market Cap $5.93M
1D Range
1.62 2.06
52W Range
1.61 94.86

Valuation (TTM)

PE -0.03
PB 0.95
EV/EBITDA -0.14

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Loading financial charts...

Profile

Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system. The company's robust deve...

Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Jun 21, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Hold
Buy (0)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.